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Abstract 
The mouse has several distinct advantages as an experimental model for study of the cochlcar blood flow (CBF) in the 
mammal, particularly for studies involving genetic manipulation, development and aging factors. In this investigation wc 
evaluated the effects of selected vasodilating agents on CBF using laser-Doppler flowmetry. Sodium nitroprussidc. hydralazinc 
and pcntoxifylline were applied topically on the round window (RW) or systemically by a subcutaneous injection. Topical 
application of sodium nitroprusside and hydralazine elevated CBF significantly, while systemic administrations of these two drugs 
failed to elevate CBF consistently. Pentoxifylline did not change CBF following topical application but increased CBF slightly 
following systemic administration. Age and gender did not influence the CBF response to topical application of sodium 
nitroprusside. 
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1. Introduction 
The mouse has several distinct advantages as an 
experimental model for human auditory function. Vari- 
ous genetic mouse models exist for conditions resem- 
bling human auditory disorders. Moreover, the mouse 
is a suitable animal for studies of the effects of aging 
on hearing, because life span of the mouse is relatively 
short and the form of sensorineural and vascular 
pathology mimics that found frequently in humans 
(Paigen et al., 1987; Li, 1992). In the past 25 years, over 
700 published articles have described various aspects of 
the auditory system of the mouse (Henry and McGinn, 
1992). However, few reports have described cochlear 
blood flow (CBF) in mice, probably because of the 
small size of the cochlea and the unavailability of 
appropriate measurement technology until relatively 
recently. In this study CBF was measured using laser- 
Doppler flowmetry in mice and the effect of aging on 
CBF response to systemically and topically applied 
vasodilating agents was investigated. 
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2. Materials and methods 
The subjects for this investigation included thirty- 
nine 2-month-old CBA mice (10 female. 29 male). 
three lo-month-old CBA mice (all male) and three 
18-month-old CBA mice (all male). 2-month-old CBA 
mice were obtained from Jackson laboratories and the 
aged mice were obtained from National Institute of 
Aging. The animals were anesthetized with subcuta- 
neous Ketamine (100 mg/kg) and Rompun (10 mg/kg), 
which was supplemented every 30 min with Ketamine 
(50 mg/kg). Core body temperature, measured with a 
rectal probe, was maintained at 37 + 1°C with a ther- 
moregulated heating blanket. 
Blood pressure (BP) in 21 of the mice was measured 
indirectly from the tail with the aid of a hydraulic 
occluder (Vascular Occluder, In Vivo Metric, CA) po- 
sitioned close to the body. The vascular occluder had a 
5 mm lumen diameter and 7 mm width. Water injected 
into the cuff tubing occluded the tail artery, while tail 
blood flow was measured by laser-Doppler flowmeter 
(TSI Laser Flo or Perimed Periflux). After the cuff 
pressure was increased sufficiently to occlude all distal 
flow in the tail, systolic BP was measured by deflating 
the cuff until blood flow began to return. BP was 
measured at several minute intervals in all except one 
of the animals in which vasodilating agents were ad- 
ministered subcutaneously, and in the 6 animals that 
received topical application of the drugs. In one ani- 
mal, the relationship between systolic BP measured by 
the tail cuff method and mean BP measured directly 
via a cannula (PElO) inserted into the left femoral 
artery was determilled while BP was altered by subcu- 
taneous injection of phenylephrin and hydralazine. In 
two animals, left carotid BP was measured directly 
through a cannula (PElO). 
The right tympanic bulla of each animal was opened 
via a ventral approach. After gently removing the mid- 
dle ear mucosa from the surface of the cochlea, a 
laser-Doppler probe was placed over the lateral wall of 
the cochlea to measure CBF. The diameter of the 
probe was 0.4 mm (Perimed PF2) or 0.8 mm (TSI Laser 
FIo). The smaller diameter probe was used in 12 of 27 
animals in which vasodilating agents were administered 
topically. Although the smalier probe gives a CBF 
reading from a smaller measurement volume, the per- 
centage change in flow for a drug stimulus was not 
altered by the probe size. A light petroleum gel was 
used to maintain a good optical coupling between the 
probe and the cochlea. The gel prevented fluid accu- 
muiation and extraneous red cells from moving under 
the probe. All recordings were done under stable illu- 
mination from the operating microscope. 
Three vasodilating agents were investigated: sodium 
nitroprusside, hydralazine and pentoxifylline were ap- 
plied topically or subcutaneously. Sodium nitroprusside 
and hydralazine are powerful vasodilators that increase 
nitric oxide (NO) which has recently been identified as 
an endothelium-derived relaxing factor (Ignarro, 1989). 
Sodium nitroprusside acts on the smooth muscle of 
both arterioles and venules, while hydralazine is a pure 
arterioiar dilator ~Shepherd and Irvine, 1986). Pentoxi- 
fylhne has a small vasodilator effect (Kaapa et al., 
1991; Sonkin et al., 1992), although the most important 
function of pentoxifylline for improving blood flow is 
the result of an increase in red blood cell flexibility. To 
administer the vasodilating agents topically, 0.4 to 2.0 
,~l quantities of agents diluted in saline were applied to 
the round window (RW) niche by a microsyringe. 
Dose-response functions were determined on the basis 
of total drug weight apphed to the RW (concentration 
of the drug times volume of the solution). 
Sodium nitrop~sside was applied topically in four- 
teen 2-month-old mice (12 males and 2 females), two 
lo-month-old mice and two l&month-old mice. The 
concentration of sodium nitroprusside applied topically 
was 0.01553.0%. In some cases of topical application 
of sodium nitroprusside, it was dissolved in distilled 
water to lower the osmolarity. Osmolarity of 3% sodium 
nitroprusside dissolved in saline and distilled water was 
534 mOsm and 273 mOsm, respectively. Acidity of 3% 
sodium nitroprusside was pH 5.1-5.2 in either solution. 
For systemic administration of sodium nitroprusside, 
0.2 mg/kg or 2 mg/kg was injected subcutaneously in 
six 2-month-old mice (all males), one IO-month-old 
mouse and one 18 month-old mouse. 
For topica application of hydralazine, nine I- 
month-old mice (6 males and 3 females) were used. 
The concentration of hydrafazine applied topicaliy was 
0.02-4.0%. Two percent hydralazine dissolved in saline 
was 384 mOsm and pH 3.9. For systemic administra- 
tion of hydralazine, 0.2 mg/kg or 2 mg/kg was injected 
subcutaneously in five 2-month-old mice (3 males and 2 
females). 
For application of pentoxifylline, 5% pentoxifylline 
was applied topically in three 2-month-old mice (2 
females and one male). Because CBF did not change 
following the topical application, subsequent injection 
of 50 mg/kg or 100 mg/kg pentoxi~lline was per- 
formed subcutaneously, In one female 2-month-old 
mouse, 50 mg/kg pentoxifylline was injected subcuta- 
neously without prior topical application of pentoxi- 
fylline. 
Changes in CBF are expressed as relative change in 
blood flow from an initial baseline. The value of the 
baseline level of CBF before the administration of the 
drug was considered as lOO%, and percentage change 
in CBF was plotted foilowing the administration. 
3. Results 
Systolic BP measured by the cuff method correlated 
well with mean BP measured directly through a can- 
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Fig. 1. Relationship, between mean blood pressure (BP) measured 
directly in the femoral artery and systolic BP measured via the tail 
cuff method. 






I I I 1 
5 10 15 20 
minutes 
1 10 loo 
sodium nitroprusside (ug) 
Fig. 2. Effects of topical application of sodium nitroprusside on Fig. 3. Dose-response curve for CBF response with topically apphed 
cochlear blood flow (CBF). Various amounts of sodium nitroprusside sodium nitropruside. Open circles show fourteen 2-month-old mice 
were applied to the round window (RW) at time 0. (Three represen- and filled circles show four aged mice. IOOr/r of CBF indicates the 
tative examples: circle:45 mg, square:18 mg, triangle:1.2 mg). baseline level before the application. 
nula inserted into a femoral artery (Fig. 1). The corre- 
lation coefficient of the linear regression was 0.94. The 
mean femoral BP was approximately 30% lower than 
the systolic BP measured via the tail cuff. BP measured 
by the cuff method immediately before drugs were 
applied was 116.3 if: 31.8 mmHg in young mice (2- 
month-old, N = 16) and 116.5 & 13.4 mmHg in the 
aged mice (lo- or l&month-old, N = 4). 
Sodium nitroprusside applied to the RW niche ele- 
vated CBF in a dose dependent manner. Fig. 2 is a 
representative example, showing that one minute foi- 
lowing topical application of a moderate and high dose 
of sodium nitroprusside, CBF began to increase and 
reached a maximum level within about lo-15 min. 
Because anesthesia time was restricted in mice (about 
2 hours), it was not possible to observe CBF for a long 
time. However, there was no obvious recovery from 
these topically induced increases during the entire du- 
ration of the experiment. Fig. 3 shows the dose-re- 
sponse CBF function obtained for topically applied 
sodium nitroprusside in 18 animals. There was no 
significant change in response to topical sodium nitro- 
prusside between young and aged mice. There was also 
no significant change in response between male and 
female mice. No difference in response was observed 
dependent on the vehicle used (saline or distilled wa- 
ter). In six animals, BP was measured before and after 
sodium nitroprusside was applied topically. No consis- 
tent change of BP was observed. 
Fig. 4 shows the effect on CBF and BP of 2 mg/kg 
sodium nitroprusside injected subcutaneously. CBF 
showed a delayed, gradual change that saturated at a 















mean and standard deviation of CBF in four animals 
were calculated for one minute intervals, a statistically 
significant increase occurred between 3 and 22 min 
after the injection (t-test, P < 0.05). By contrast, BP 
decreased L-35% in 2-10 min following injection. 
Both tend toward recovery. With 0.2 mg/kg sodium 
nitroprusside, BP still showed a 15-3.5% decrease but 
the increase in CBF was under about lo-20% (Fig. 5). 
These data indicate that the sodium nitroprusside ef- 
fect on peripheral vessels is relatively saturated at 
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Fig. 4. Effect of 2 mg/kg sub~~ltaneous sodium nitroprusside on CBF 
and BP. Open symbols mean CBF and closed symbols mean BP. The 
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Fig. 5. Effect of 0.2 mg/kg subcutaneous sodium nitroprusside on 
CBF and BP. Open symbols mean CBF and closed symbols mean 
BP. The symbols represent four animals. 
0 I I I I I I 1 
0 5 10 15 20 25 30 
minutes 
Fig. 7. Effect of 0.2 mg/kg or 2 mg/kg subcutaneous hydralazine on 
CBF and BP. Open symbols mean CBF and closed symbols mean 
BP. Two animals shown by triangles received 2 mg/kg and the other 
three animals received 0.2 mg/kg. 
tion of cochlear vessels is not. One l&month-old mouse 
died 20 min after subcutaneous injection of 0.2 mg/kg 
sodium nitroprusside. 
Hydralazine applied to the RW niche also increased 
CBF in a dose dependent manner. CBF began to 
increase 2 or 3 min after the application of hydrala- 
zine, and reached a maximum level within 10 min. 
Generally speaking, the CBF changes caused by topi- 
cally applied hydralazine were similar to those of 
sodium nitroprusside. However, in two cases that 
showed an increase in CBF of less than 40% following 
application of the drug, CBF began to return toward 
the baseline within 30 min following the peak response 
level. The relationship between the total weight of 
hydralazine applied topically and the maximum re- 
sponse observed in CBF is shown in Fig. 6. There was 
no significant difference in response between males 
and females. We also did not find any difference in the 
response to topical application of sodium nitroprusside 
based on the diameter of probe (0.4 mm or 0.8 mm). 
The effect of subcutaneously injected hydralazine 
(0.2 mg/kg or 2 mg/kg) on CBF is shown in Fig. 7. 
Following subcutaneous injection of hydralazine, BP 
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Fig. 6. Dose response curve for CBF response with topically applied 
hydralazine (nine 2-month-old mice). 
Fig. 8. Effect of 50 mg/kg or 100 mg/kg pentoxifylline on CBF and 
BP. Open symbols mean CBF and closed symbols mean BP. Two 
animals, shown by triangles, received 100 mg/kg. 
hydralazine was injected. An increase in CBF was 
observed in 1 of 3 animals administered 0.2 mg/kg 
hydralazine and in 1 of 2 animals receiving 2 mg/kg 
hydralazine. In the 2 animals in which CBF increased 
following subcutaneous injection of hydralazine, BP 
was measured directly through a cannula inserted into 
the carotid artery. 
Pentoxifylline did not increase CBF when 30-50 mg 
was applied topically to the RW niche in 3 animals. 
When pentoxifylline was injected subcutaneously (50 
mg/kg or 100 mg/kg), CBF increased by lo-20% 
within approximately 5 min in 3 of 4 animals without 
significant change of BP (Fig. 8). This CBF increase 
appeared to recover to baseline within 20 min of the 
subcutaneous injection (3 of 4 animals). 
4. Discussion 
It was possible to measure CBF in the mouse using 
laser-Doppler flowmetry. It thus appears that the sta- 
tus of CBF in various genetic mouse models of sen- 
sorineural hearing loss can be studied to investigate the 
role of CBF disturbance in inner ear deafness. The 
other advantage of the mouse rests with the availability 
of aged mice to study the relationship of CBF and 
functional changes in the inner ear with aging. Disad- 
vantages of mice in the investigation of CBF are diffi- 
culty with cannulation of arteries or veins for BP 
measurement or drug administration, and difficulties 
with maintaining this small animal in a good physio- 
logical state for extended periods under anesthesia. 
This is generally due to respiratory deterioration. 
To reduce the experiment time in the current study, 
a cuff method for measurement of BP of the tail artery 
was used in these studies. The cuff method has been 
widely used in many strains of young and aged mice for 
measurement of BP (Schlager, 1966; Weibust and 
Schlager, 1968). These studies showed that age related 
changes in BP may be quite different from strain to 
strain. In the CBA strain of mice, no increase of BP 
was observed with age after maturation (Henry et al.. 
1965). In the current study using CBA strain, the 
average BP was not different between young and aged 
mice. 
We investigated the effect of 3 vasodilating agents: 
sodium nitroprusside, hydralazine and pentoxifylline 
on CBF in mice. Sodium nitroprusside and hydrala- 
zine, as powerful vasodilators, are used to lower severe 
hypertension. Sodium nitroprusside demonstrated a 
more pronounced effect on BP than CBF. This may be 
related to the generally powerful effect of nitric oxide 
as a vasodilator. Considering the facts that the amount 
of sodium nitroprusside required to increase CBF in 
mice exceeds clinical dosage per body weight and that 
the clinical dosage of sodium nitroprusside typically 
used does not increase cerebral blood flow (Tinker and 
Michenfelder, 1976; Ivankovich et al.. lY76), it is possi- 
ble that systemic administration of sodium nitroprus- 
side would not increase CBF to a clinically useful 
degree. 
Hydralazine did not increase CBF except in two 
cases. It is not clear why this was so. The effect ot 
hydralazine on CBF has been studied earlier by Snow 
and Suga (1973) using impedance plethysmography in 
guinea pigs. They reported an increase of CBF with a 
drop in BP following intravenous injection of hydrala- 
zine. Miller et al. (1986) and Ohlsen et al. (IYY2). 
however, reported no increase in CBF using Iaser-Dop- 
pler flowmetry in guinea pigs, combined with ;I de- 
crease in BP following systemic administration of hy- 
dralazine. This must mean that some cochlear vasodila- 
tion occurred to counteract the decreased systemic BP. 
Overall, the influence of systemically administered va- 
sodilating agents on CBF is complicated by the dilata- 
tion of blood vessels in the whole body and the con- 
comitant hypotension. 
Subcutaneous administration of pentoxifylline in- 
creased CBF, a finding in agreement with previous 
observations (LaRouere et al.. 1YYO: Coleman et al.. 
19YO). This increase in CBF may reflect the rhcological 
changes induced by pentoxifylline on blood viscosity 
and plasticity of red blood cells (Smith ct al.. IYSh: Dc 
Felice et al.. 1990: Mollitt and Poulos, IYYl ). 
Topical application of vasodilating agents is an ef- 
fective method to dramatically incrcasc (‘BF. If the 
molecular weight of the drug is below SO(J. the drug can 
pass through the round window membrane (Juhn et al.. 
1987). Three kinds of drugs wc used have molecular 
weight less than 300. Ohlsen et al. (1092) obscrvcd 
significant increases in CBF following application of 
sodium nitroprusside or hydralazinc to the KW in 
guinea pigs. We confirmed these strong effects of topi- 
cal application of these drugs on CBF in the mouse. 
Obviously toxic effects of these drugs must bc studied 
in order to evaluate clinical usefulness (Ohlscn et al.. 
1993). Topical application of pentoxifyllinc was tried in 
the present study without significant effect on C‘BF. 
This is consistent with its primary effect on red cells. 
Our study did not show significant difference in 
response of CBF to topically applied sodium nitroprus- 
side between young and aged mice. However. the old- 
est mice were only 18 months of age. This result is 
consistent with previous reports that investigated the 
effect of aging on response of blood vessels to topical 
sodium nitroprusside in other vascular systems. c.g. the 
basilar artery (Hatake et al.. IYYO) or the brachial 
artery (Imaizumi et al.. 19YO). However. with systemic 
administration of sodium nitroprussidc, elderly aubjccth 
demonstrated an increased sensitivity (Irvine and 
Shepherd. 1084; Minaker et al.. IYYI ), presumably in 
part because baroreflex function decrcascd with age. 
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Effects of aging on CBF are important in relation to 
presbycusis (Johnsson and Hawkins, 1976; Gates et al., 
1993). Prazma et al. (1990) reported that CBF de- 
creased in 2- to 3-year old gerbils. Hillerdal et al. 
(1987), however, observed that CBF in 8- to 24-month- 
old normotensive rats was not significantly different 
from that found in 3-to 6-month-old normotensive rats. 
The effect of age on CBF may be different in each 
animal according to its life span. Because life span of 
the mouse is short (about two years) and many aging 
studies have been performed in mice, we suggest that 
the mouse is a useful model to extend our knowledge 
of the basis for and the role of CBF in age related 
hearing changes of presbycusis. 
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